2. Cell Cycle/DNA Damage Cytoskeleton Apoptosis Autophagy
  3. Microtubule/Tubulin Apoptosis Autophagy
  4. Nab-Paclitaxel

Nab-Paclitaxel  (Synonyms: Nanoparticle albumin-bound Paclitaxel; Nanoparticle albumin-bound ABI-007)

製品番号: HY-P99974 Assay: 99.9%
COA Technical Support

Nab-Paclitaxel (Nanoparticle albumin-bound Paclitaxel) is an albumin-bound nanoparticle formulation of Paclitaxel (HY-B0015). Nab-Paclitaxel is composed of albumin and the active pharmaceutical ingredient Paclitaxel, in which human albumin is used as an excipient to disperse and stabilize particles and carry the main drug. Nab-Paclitaxel is a solvent-free taxane with higher response rates and improved tolerability. Nab-Paclitaxel displays less toxicity and greater antitumor activity. Nab-Paclitaxel is more readily available for tumor cell uptake in three rhabdomyosarcoma, seven neuroblastoma cell lines, and one ostersarcoma cell line Nab-Paclitaxel can be studied in cancer research for example breast cancer and solid tumors. (The product specifications below only indicate the effective content of Paditaxel, the actual albumin quality depends on the batch; the ratio of each ingredient in this product is Paditaxel: albumin -1:7~1:11).

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

容量 価格（税別） 在庫状況 数量
1 mg $35 在庫あり
5 mg $60 在庫あり
10 mg $85 在庫あり
25 mg $160 在庫あり
50 mg $255 在庫あり
100 mg $410 在庫あり
200 mg   お問い合わせ  
500 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 4 publication(s) in Google Scholar

Nab-Paclitaxel Featured Recommendations:

Nab-Paclitaxel 関連抗体

Top Publications Citing Use of Products

    Nab-Paclitaxel purchased from MedChemExpress. Usage Cited in: Mol Cancer. 2024 Sep 30;23(1):215.  [Abstract]

    Sulindac K-80003 restored sensitivity to AG (10 nM, 48 h) significantly shrunk tumors arising and prolonged the median survival in the corresponding PDOX model.

    Nab-Paclitaxel purchased from MedChemExpress. Usage Cited in: Mol Cancer. 2024 Sep 30;23(1):215.  [Abstract]

    Mice were treated with saline, the dual combination of gemcitabine (25 mg/kg, weekly), and nab-paclitaxel (15 mg/kg, weekly; red arrows), or the triple combination of gemcitabine and nab-paclitaxel (as dosed for the monotherapies) plus K-80003 (20 mg/kg, twice weekly; blue arrows) for 3 weeks. Tumors were harvest at 3 weeks after treatment. Survival curves for mice that received different treatments (5 mice per group).

    • 生物活性

    • 純度とドキュメンテーション

    • 参考文献

    • カスタマーレビュー

    製品説明

    Nab-Paclitaxel (Nanoparticle albumin-bound Paclitaxel) is an albumin-bound nanoparticle formulation of Paclitaxel (HY-B0015). Nab-Paclitaxel is composed of albumin and the active pharmaceutical ingredient Paclitaxel, in which human albumin is used as an excipient to disperse and stabilize particles and carry the main drug. Nab-Paclitaxel is a solvent-free taxane with higher response rates and improved tolerability. Nab-Paclitaxel displays less toxicity and greater antitumor activity. Nab-Paclitaxel is more readily available for tumor cell uptake in three rhabdomyosarcoma, seven neuroblastoma cell lines, and one ostersarcoma cell line Nab-Paclitaxel can be studied in cancer research for example breast cancer and solid tumors. (The product specifications below only indicate the effective content of Paditaxel, the actual albumin quality depends on the batch; the ratio of each ingredient in this product is Paditaxel: albumin -1:7~1:11)[1][2].

    体外実験

    Nab-Paclitaxel (0.1 nM-10 μM, 72 h) is more readily available for tumor cell uptake in three rhabdomyosarcoma, seven neuroblastoma cell lines, and one ostersarcoma cell line[3].
    Nab-Paclitaxel (12-120 nM, 48 h) increases apoptotic RH4 cells and most cells detaches from the coveslips with higher concentration (60 or 120 nM)[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Nab-Paclitaxel 関連抗体

    Cell Cytotoxicity Assay[3]

    Cell Line: Three rhabdomyosarcoma cell lines(RH4, RH30, and RD), seven neuroblastoma cell lines (CHLA-20, CHLA-15, CHLA-90, LAN-5, SK-N-BE(2), BE(2)C, and SH-SY5Y) and one osteosarcoma cell line (KHOS)
    Concentration: 0.1 nM, 1 nM, 10 nM, 100 nM, 1 μM, 10 μM
    Incubation Time: 72 h
    Result: Reduced the cell viability of the three rhabdomyosarcoma cell lines with IC50 ranging from 0.56 to 4.68 nM.
    Exhibited dose-dependent cytotoxicity in seven neuroblastoma cell lines, where CHLA-20 has the highest IC50 of 36 nM.
    体内実験

    Nab-Paclitaxel (30-50 mg/kg, i.v., administer on day 1, 8, 15) significantly inhibits RH4 tumor growth with tumor regression after second dosage on day 8 in mice bearing rhabdomyosarcoma (RH4 and RD) xenografts[3].
    Nab-Paclitaxel (2-10 mg/kg, i.v., daily) significantly inhibits tumor growth with 5 and 10 mg/kg in neuroblastoma (SK-N-BE (2) and CHLA-20) xenograft (s.c.) mice[3].
    Nab-Paclitaxel (50 mg/kg, i.v., weekly) has the strongest antitumor activity and significantly prolongs animal survival[3].
    Nab-Paclitaxel (10 mg/kg, i.v., 5 consecutive days or 50 mg/kg, i.v., weekly) displays lower plasma paclitaxel concentrations but higher intratumor paclitaxel concentrations in both rhabdomyosarcoma and neuroblastoma mice model[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Female NOD/SCID (nonobese diabetic/severe combined immunodeficient) mice 4- to 6-week old bearing rhabdomyosarcoma (RH4 and RD) xenografts[3]
    Dosage: 30, 50 mg/kg
    Administration: Intravenous injection (i.v.), administer on day 1, 8, 15 then 52, 59, 66
    Result: Exhibited lower toxicity to mice compared with Paclitaxel.
    Increased local relapse-free intervals.
    Significantly inhibited tumor growth and led to tumor shrinkage.
    Remained sensitivity in mice with relapse RH4 xenografts against Nab-Paclitaxel whilst the xenografts were drug resistant against Paclitaxel.
    Led to complete regression after day 29, but a few had relapsed tumor after 37 to 42 days.
    Animal Model: Female NOD/SCID (nonobese diabetic/severe combined immunodeficient) mice 4- to 6-week old bearing rhabdomyosarcoma or neuroblastoma xenografts[3]
    Dosage: 10 mg/kg for 5 consecutive days or 50 mg/kg weekly
    Administration: Intravenous injection (i.v.)
    Result: Significantly increased apoptotic cell population in a dose-dependent manner.
    Increased phospho-histone H3-positive cells in a dose-dependent manner.
    Induced G2-M cell-cycle arrest.
    臨床実験
    Application

    ELISA, FACS, Functional assay
    Conjugated

    Unconjugated
    Reconsititution

    The product can be reconstituted/diluted with sterile PBS or saline.
    分子量

    853.91 Da

    Appearance

    Solid

    Color

    White to off-white

    SMILES

    [Nab-Paclitaxel]
    Formulation

    Please refer to the lot-specific COA for specific buffer information.
    保管条件

    Please store the product under the recommended conditions in the Certificate of Analysis.
    純度とドキュメンテーション

    純度: 99.9%

    COA (232 KB)

    Inhibitory Antibodies User Guide (603 KB)
    参考文献
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.

    Nab-Paclitaxel Related Classifications

    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    質量   濃度   体積   分子量 *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます：C1V1 = C2V2

    濃度 （開始） × 体積 （開始） = 濃度 （終了） × 体積 （終了）
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Keywords:

    Nab-PaclitaxelNanoparticle albumin-bound Paclitaxel Nanoparticle albumin-bound ABI-007Microtubule/TubulinApoptosisAutophagyAlbuminantitumorbreast cancerInhibitorinhibitorinhibit

    最近チェックした製品:

    オンラインお問い合わせ

    Your information is safe with us. * Required Fields.

    製品名

    		  

    カスタマ需要量 *

    お名前 *

    		 

    タイトル

    メールアドレス *

    		 

    電話番号 *

    デパートメント

    		 

    組纖名 *

    市区町村

    都道府県

    国或いは地域 *

    		      

    必ず会社名を記載ください。個人への返信は行いません。

    備考

    バルクお問い合わせ

    Inquiry Information

    製品名:
    Nab-Paclitaxel
    製品番号:
    HY-P99974
    数量:
    MCE 日本正規代理店:

    カスタマーレビュー

    Thank You for Your Feedback!

    Request for HNMR Report

    Please fill out this form to request the QC report. We will send it to your Email address shortly.

    Your information is safe with us. * Required Fields.

    製品名

    		  

    Lot #

    お名前 *

    		 

    メールアドレス *

    電話番号 *

    		 

    部門 *

    組纖名 *

    		 

    国或いは地域 *

    備考

    Request for HNMR Report

    We have received your request and will respond to you as soon as possible.